Sanjay Hari
Investor Relations
Replay available
inTest Corporation (AMEX: INTT) Q4 2025 earnings conference call, held 2026-02-27. Replay captured from the company's public earnings webcast.

Investor Relations
Chief Financial Officer and Treasurer
Analyst, Lake Street Capital Markets
President and Chief Executive Officer
Analyst, Oak Ridge
Analyst, Northland Securities
Greetings. Welcome to Intest Corporation's fourth quarter 2025 financial results conference call. At this time, all participants are in listen-only mode. The question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. Please note that today's conference is being recorded. At this time, I'll now turn the conference over to Sanjay Hari of Investor Relations. Please go ahead, Sanjay. Good morning, everyone, and thank you for joining us. With me on the call are Nick Grant, President and Chief Executive Officer, and Duncan Gilmore, Chief Financial Officer and Treasurer. The earnings press release was issued this morning, as well as the slides that management will use during this call. Both can be found in the investor relations section of the intest.com website. Please turn to slide two for a review of the Safe Harbor Statement. During this call, management will make some forward-looking statements about our current plans, beliefs, and expectations. These statements apply to future events that are subject to risks, uncertainties, and other factors that could cause actual results to differ materially from what is stated here today. These risks, uncertainties, and other factors are provided in the earnings release, as well as in other documents filed by the company with the Securities and Exchange Commission. These documents can be found on our website or at sec.gov. Also, as covered in slide three, management will refer to some non-GAAP financial measures. We believe these will be useful in evaluating the company's performance. However, you should not consider the presentation of this additional information in isolation or as a substitute for results pr...